{"entity":{"type":"insider","cik":"0001715153","url":"/insider/0001715153","json_url":"/insider/0001715153.json","name":"Bristol James Arthur","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":13,"first":"2019-02-07","last":"2022-12-22","span_basis":"filed_date"},"name_variants":[{"name":"Bristol James Arthur","source":"filing","n_filings":13,"first_seen":"2019-02-07","last_seen":"2022-12-22"}],"transactions":[{"id":6354490,"accession":"0001209191-22-062536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062536","line_url":"/filing/0001209191-22-062536#line-1","is_derivative":false,"issuer_cik":"0001715153","issuer_name":"Erasca, Inc.","issuer_ticker":"ERAS","issuer_name_source":null,"issuer_url":"/issuer/0001715153","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":4.14,"price_display":"4.14","price_state":"stated","total_value":82800.0,"total_display":"82,800.00","total_whole":"82,800","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-22","scope":"insider"},{"id":4936326,"accession":"0001209191-21-027789","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-027789","line_url":"/filing/0001209191-21-027789#line-5","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":45.5963,"price_display":"45.60","price_state":"stated","total_value":77513.71,"total_display":"77,513.71","total_whole":"77,514","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-20","filed_date":"2021-04-21","scope":"insider"},{"id":4936318,"accession":"0001209191-21-027789","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-027789","line_url":"/filing/0001209191-21-027789","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5300.0,"shares_display":"5,300","price_per_share":46.26038301886793,"price_display":"46.26","price_state":"stated","total_value":245180.03,"total_display":"245,180.03","total_whole":"245,180","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider","n_lines":2},{"id":4824997,"accession":"0001209191-21-026633","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-026633","line_url":"/filing/0001209191-21-026633","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14700.0,"shares_display":"14,700","price_per_share":43.83745585714286,"price_display":"43.84","price_state":"stated","total_value":644410.6011,"total_display":"644,410.60","total_whole":"644,411","shares_owned_after":5217.0,"shares_owned_after_display":"5,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-14","scope":"insider","n_lines":2},{"id":4772543,"accession":"0001209191-21-004246","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-004246","line_url":"/filing/0001209191-21-004246","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":50.29134857142857,"price_display":"50.29","price_state":"stated","total_value":352039.44,"total_display":"352,039.44","total_whole":"352,039","shares_owned_after":600.0,"shares_owned_after_display":"600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-20","scope":"insider","n_lines":2},{"id":2658127,"accession":"0001209191-20-054633","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-054633","line_url":"/filing/0001209191-20-054633","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23541.0,"shares_display":"23,541","price_per_share":53.56903143876641,"price_display":"53.57","price_state":"stated","total_value":1261068.5691,"total_display":"1,261,068.57","total_whole":"1,261,069","shares_owned_after":4171.0,"shares_owned_after_display":"4,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-09","filed_date":"2020-10-13","scope":"insider","n_lines":3},{"id":3010852,"accession":"0001209191-20-042243","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-042243","line_url":"/filing/0001209191-20-042243","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23541.0,"shares_display":"23,541","price_per_share":54.99484108151735,"price_display":"54.99","price_state":"stated","total_value":1294633.5539,"total_display":"1,294,633.55","total_whole":"1,294,634","shares_owned_after":11180.0,"shares_owned_after_display":"11,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-09","filed_date":"2020-07-13","scope":"insider","n_lines":4},{"id":3256332,"accession":"0001209191-20-024252","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-024252","line_url":"/filing/0001209191-20-024252","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23542.0,"shares_display":"23,542","price_per_share":43.829744125392914,"price_display":"43.83","price_state":"stated","total_value":1031839.8362,"total_display":"1,031,839.84","total_whole":"1,031,840","shares_owned_after":536.0,"shares_owned_after_display":"536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-09","filed_date":"2020-04-13","scope":"insider","n_lines":4},{"id":2486347,"accession":"0001209191-20-001755","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-20-001755","line_url":"/filing/0001209191-20-001755","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7989.0,"shares_display":"7,989","price_per_share":57.35329773438478,"price_display":"57.35","price_state":"stated","total_value":458195.4956,"total_display":"458,195.50","total_whole":"458,195","shares_owned_after":2010.0,"shares_owned_after_display":"2,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-06","scope":"insider","n_lines":4},{"id":2486324,"accession":"0001209191-20-001755","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-001755","line_url":"/filing/0001209191-20-001755","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15553.0,"shares_display":"15,553","price_per_share":57.83241636983219,"price_display":"57.83","price_state":"stated","total_value":899467.5718,"total_display":"899,467.57","total_whole":"899,468","shares_owned_after":6012.0,"shares_owned_after_display":"6,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider","n_lines":4},{"id":8619690,"accession":"0001209191-19-055179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-055179","line_url":"/filing/0001209191-19-055179#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":45.0729,"price_display":"45.07","price_state":"stated","total_value":1126822.5,"total_display":"1,126,822.50","total_whole":"1,126,823","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-01","filed_date":"2019-11-05","scope":"insider"},{"id":8418606,"accession":"0001209191-19-045816","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-045816","line_url":"/filing/0001209191-19-045816","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":39.974614068,"price_display":"39.97","price_state":"stated","total_value":999365.3517,"total_display":"999,365.35","total_whole":"999,365","shares_owned_after":800.0,"shares_owned_after_display":"800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-13","scope":"insider","n_lines":4},{"id":8556410,"accession":"0001209191-19-011360","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-011360","line_url":"/filing/0001209191-19-011360#line-4","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17782.0,"shares_display":"17,782","price_per_share":28.0398,"price_display":"28.04","price_state":"stated","total_value":498603.7236,"total_display":"498,603.72","total_whole":"498,604","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-15","filed_date":"2019-02-19","scope":"insider"},{"id":8556402,"accession":"0001209191-19-011360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-011360","line_url":"/filing/0001209191-19-011360#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1101.0,"shares_display":"1,101","price_per_share":28.0126,"price_display":"28.01","price_state":"stated","total_value":30841.8726,"total_display":"30,841.87","total_whole":"30,842","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-14","filed_date":"2019-02-19","scope":"insider"},{"id":8615325,"accession":"0001209191-19-010144","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-010144","line_url":"/filing/0001209191-19-010144#line-4","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2922.0,"shares_display":"2,922","price_per_share":28.0067,"price_display":"28.01","price_state":"stated","total_value":81835.5774,"total_display":"81,835.58","total_whole":"81,836","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-13","filed_date":"2019-02-14","scope":"insider"},{"id":8615321,"accession":"0001209191-19-010144","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-010144","line_url":"/filing/0001209191-19-010144#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":28.0017,"price_display":"28.00","price_state":"stated","total_value":16801.02,"total_display":"16,801.02","total_whole":"16,801","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-14","scope":"insider"},{"id":8023057,"accession":"0001209191-19-008046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-008046","line_url":"/filing/0001209191-19-008046#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001715153","owner_name":"Bristol James Arthur","owner_display_name":"Bristol James Arthur","owner_url":"/insider/0001715153","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2595.0,"shares_display":"2,595","price_per_share":28.017,"price_display":"28.02","price_state":"stated","total_value":72704.115,"total_display":"72,704.12","total_whole":"72,704","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":36,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001761918","name":"Erasca, Inc.","url":"/issuer/0001761918","role":"Director","n_filings":1,"first_seen":"2022-12-22","last_seen":"2022-12-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001654151","name":"Deciphera Pharmaceuticals, Inc.","url":"/issuer/0001654151","role":"Director","n_filings":12,"first_seen":"2019-02-07","last_seen":"2021-04-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001715153","retrieved_at":"2026-08-25T01:13:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}